Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer.

Madeddu, Clelia; Kotsonis, Paraskevas; Lavra, Fabrizio; Chiappe, Giacomo; Melis, Luca; Mura, Ester; Scartozzi, Mario; Macciò, Antonio

Madeddu, Clelia; Kotsonis, Paraskevas; Lavra, Fabrizio; Chiappe, Giacomo; Melis, Luca; Mura, Ester; Scartozzi, Mario; Macciò, Antonio.

Afiliação

Madeddu C; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Kotsonis P; Department of Gynecologic Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Lavra F; Department of Gynecologic Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Chiappe G; Department of Gynecologic Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Melis L; Department of Nuclear Medicine, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Mura E; Department of Pathology, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Scartozzi M; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Macciò A; Department of Gynecologic Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy.

Oncotarget ; 10(21): 2012-2021, 2019 Mar 12.

Article em En | MEDLINE | ID: mdl-31007844

Palavras-chave

cervical cancer; immunotherapy; laparoscopic total pelvic exenteratio; next-generation sequencing; synchronous cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google